Max India has received approved for the sale of its 51% stake in Max Bupa Health Insurance Company (Max Bupa) to True North. The all-cash transaction values Max Bupa at an enterprise value of Rs 1,001 crore. The Board of Directors of the Company at its meeting held on February 26, 2019 has approved the same.
Bupa, the existing joint venture partner in Max Bupa, remains committed to the joint venture and will continue to play an active role in the company. At the conclusion of the transaction, True North will nominate directors on Max Bupa's Board, while Max India's nominated directors will step down. The use of the Max brand will be phased out over a period of two years and replaced with a suitable name.
The transaction will lead to a cash inflow of Rs 511 crore for Max India. The company intends to utilize the proceeds to invest in both existing and new business opportunities which are currently under evaluation.
Max India is engaged in the business of investments and providing consultancy services to group companies. The company’s segments are Healthcare Business, Business Investments, Health Insurance, Senior Living and Others.
Company Name | CMP |
---|---|
Bajaj Finserv | 1559.80 |
Paul Merchants | 938.05 |
IIFL Finance | 409.55 |
Altius Telecom Infra | 150.00 |
Embassy Office Parks | 373.87 |
View more.. |